ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,805
0,21%
Bitcoin
59 320,87
0,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Denali Therapeutics Inc (DNLI)

  7. Denali Therapeutics Inc (DNLI) Actualités

DNLI Denali Therapeutics Inc

17,00
0,84 (5,20%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Denali Therapeutics Inc DNLI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,84 5,20% 17,00 00:00:45
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
16,41 15,92 16,94 16,81 16,16
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:00GLOBEDenali Therapeutics Announces Completion of Enrollment for..
01/3/202422:51EDGAR2Form D - Notice of Exempt Offering of Securities
27/2/202414:07EDGAR2Form 8-K - Current report
27/2/202414:05GLOBEDenali Therapeutics Reports Fourth Quarter and Full Year..
27/2/202414:03EDGAR2Form 8-K - Current report
27/2/202414:00GLOBEDenali Therapeutics Announces $500 million Private Placement..
16/2/202414:02EDGAR2Form 8-K - Current report
16/2/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:59EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:43EDGAR2Form 144 - Report of proposed sale of securities
14/2/202402:19EDGAR2Form 144 - Report of proposed sale of securities
14/2/202402:18EDGAR2Form 144 - Report of proposed sale of securities
14/2/202402:17EDGAR2Form 144 - Report of proposed sale of securities
12/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202414:00GLOBEDenali Therapeutics Announces New Data and Expansion of Its..
01/2/202414:00GLOBEDenali Therapeutics Announces Presentations on Its..
13/1/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:09EDGAR2Form 144 - Report of proposed sale of securities
10/1/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:20EDGAR2Form 144 - Report of proposed sale of securities
08/1/202414:06EDGAR2Form 8-K - Current report
08/1/202414:00GLOBEDenali Therapeutics Announces Key Anticipated 2024..
06/1/202402:25EDGAR2Form 144 - Report of proposed sale of securities
05/1/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
07/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:04EDGAR2Form 8-K - Current report
07/11/202322:01GLOBEDenali Therapeutics Reports Third Quarter 2023 Financial..
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/9/202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/8/202314:30GLOBEDenali Therapeutics Announces New Interim Data from Phase..
29/8/202315:00PRNUSInvaio achieves first registration for citrus greening..
25/8/202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:07EDGAR2Form 144 - Report of proposed sale of securities
23/8/202322:06EDGAR2Form 144 - Report of proposed sale of securities
21/8/202322:06EDGAR2Form 8-K - Current report
21/8/202320:47EDGAR2Form 144 - Report of proposed sale of securities
21/8/202320:45EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
DNLI
Denali Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés